NanoViricides Inc. (NNVC)

[JG36]

But it is irrelevant. It would be relevant if NNVC had a product to sell today, which they would have had they met their first announced time table for Flucide (or their second), but they don't.

The idea that a flu outbreak will suddenly make investors think about flu cures so snap up shares of NNVC is silly. Everybody with more than $500 to invest is well aware that outbreaks of serious strains of flu pop up on pretty much an annual basis. There is no disagreement among investors that a real cure for the flu would be desirable to have and probably very profitable for its inventor. There is plenty of skepticism that NNVC will ever deliver such a cure.